Acikgoz Y, Ergun Y, Ucar G, Dirikoc M, Uncu D. The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients: Her2-positive metastatic breast cancer patients. Acta Medica [Internet]. 2019 Dec. 31 [cited 2024 Apr. 18];50(4):14-9. Available from: https://actamedica.org/index.php/actamedica/article/view/395